Illumina Body Map 2 (GSE30611)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
BATF
|
ENSG00000156127.8 | basic leucine zipper ATF-like transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
BATF | hg38_v1_chr14_+_75522531_75522560 | 0.27 | 1.3e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_-_89010515 | 5.37 |
ENST00000493819.1
|
IGKV1-9
|
immunoglobulin kappa variable 1-9 |
chr22_+_22711689 | 5.05 |
ENST00000390308.2
|
IGLV3-21
|
immunoglobulin lambda variable 3-21 |
chr2_+_88885397 | 4.83 |
ENST00000390243.2
|
IGKV4-1
|
immunoglobulin kappa variable 4-1 |
chr14_-_106622837 | 4.16 |
ENST00000390628.3
|
IGHV1-58
|
immunoglobulin heavy variable 1-58 |
chr3_+_151814102 | 4.14 |
ENST00000232892.12
|
AADAC
|
arylacetamide deacetylase |
chr2_+_89947508 | 4.13 |
ENST00000491977.1
|
IGKV2D-29
|
immunoglobulin kappa variable 2D-29 |
chr2_-_89320146 | 4.03 |
ENST00000498574.1
|
IGKV1-39
|
immunoglobulin kappa variable 1-39 |
chr17_-_40565459 | 3.95 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
C-C motif chemokine receptor 7 |
chr4_+_40191037 | 3.94 |
ENST00000505618.5
|
RHOH
|
ras homolog family member H |
chr14_-_94388589 | 3.85 |
ENST00000402629.1
ENST00000556091.1 ENST00000393087.9 ENST00000554720.1 |
SERPINA1
|
serpin family A member 1 |
chr2_+_89959979 | 3.80 |
ENST00000453166.2
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
chr2_+_90220727 | 3.47 |
ENST00000471857.2
|
IGKV1D-8
|
immunoglobulin kappa variable 1D-8 |
chr2_+_90100235 | 3.43 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr1_+_160739286 | 3.35 |
ENST00000359331.8
ENST00000495334.1 |
SLAMF7
|
SLAM family member 7 |
chr22_+_22369601 | 3.30 |
ENST00000390295.3
|
IGLV7-46
|
immunoglobulin lambda variable 7-46 |
chr22_+_22822658 | 3.29 |
ENST00000620395.2
|
IGLV2-8
|
immunoglobulin lambda variable 2-8 |
chr2_+_89862438 | 3.25 |
ENST00000448155.2
|
IGKV1D-39
|
immunoglobulin kappa variable 1D-39 |
chr22_+_22720615 | 3.12 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr2_-_89222461 | 3.05 |
ENST00000482769.1
|
IGKV2-28
|
immunoglobulin kappa variable 2-28 |
chr5_+_35856883 | 3.04 |
ENST00000506850.5
ENST00000303115.8 ENST00000511982.1 |
IL7R
|
interleukin 7 receptor |
chr22_+_22395005 | 3.02 |
ENST00000390298.2
|
IGLV7-43
|
immunoglobulin lambda variable 7-43 |
chr1_-_159076742 | 2.98 |
ENST00000368130.9
|
AIM2
|
absent in melanoma 2 |
chr22_+_22697789 | 2.97 |
ENST00000390306.2
|
IGLV2-23
|
immunoglobulin lambda variable 2-23 |
chr2_+_90159840 | 2.95 |
ENST00000377032.5
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr2_+_102001966 | 2.92 |
ENST00000457817.5
|
IL1R2
|
interleukin 1 receptor type 2 |
chr14_+_21868822 | 2.84 |
ENST00000390436.2
|
TRAV13-1
|
T cell receptor alpha variable 13-1 |
chr17_-_31314040 | 2.78 |
ENST00000330927.5
|
EVI2B
|
ecotropic viral integration site 2B |
chr4_+_40196907 | 2.77 |
ENST00000622175.4
ENST00000619474.4 ENST00000615083.4 ENST00000610353.4 ENST00000614836.1 |
RHOH
|
ras homolog family member H |
chr22_+_22668286 | 2.76 |
ENST00000390304.2
|
IGLV3-27
|
immunoglobulin lambda variable 3-27 |
chr22_+_22380766 | 2.71 |
ENST00000390297.3
|
IGLV1-44
|
immunoglobulin lambda variable 1-44 |
chr14_-_106762576 | 2.71 |
ENST00000624687.1
|
IGHV1-69D
|
immunoglobulin heavy variable 1-69D |
chr3_+_151814069 | 2.68 |
ENST00000488869.1
|
AADAC
|
arylacetamide deacetylase |
chr1_-_153375591 | 2.67 |
ENST00000368737.5
|
S100A12
|
S100 calcium binding protein A12 |
chr14_-_106511856 | 2.63 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr19_+_41877267 | 2.62 |
ENST00000221972.8
ENST00000597454.1 ENST00000444740.2 |
CD79A
|
CD79a molecule |
chr22_+_22818994 | 2.62 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 |
chr7_+_142328282 | 2.62 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
chr14_-_24634160 | 2.59 |
ENST00000616551.1
ENST00000382542.5 ENST00000216341.9 ENST00000526004.1 ENST00000415355.7 |
GZMB
|
granzyme B |
chr22_+_22357739 | 2.57 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr2_-_89100352 | 2.56 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr9_-_114078293 | 2.52 |
ENST00000265132.8
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr14_-_106715166 | 2.50 |
ENST00000390633.2
|
IGHV1-69
|
immunoglobulin heavy variable 1-69 |
chr1_+_17308194 | 2.50 |
ENST00000375453.5
ENST00000375448.4 |
PADI4
|
peptidyl arginine deiminase 4 |
chr17_-_31314066 | 2.46 |
ENST00000577894.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr22_+_22734577 | 2.43 |
ENST00000390310.3
|
IGLV2-18
|
immunoglobulin lambda variable 2-18 |
chr2_-_88992903 | 2.43 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr10_+_5048748 | 2.42 |
ENST00000602997.5
ENST00000439082.7 |
AKR1C3
|
aldo-keto reductase family 1 member C3 |
chr3_-_42875871 | 2.36 |
ENST00000316161.6
ENST00000437102.1 |
CYP8B1
|
cytochrome P450 family 8 subfamily B member 1 |
chr3_-_9878765 | 2.36 |
ENST00000430427.6
ENST00000383817.5 ENST00000679265.1 |
CIDEC
|
cell death inducing DFFA like effector c |
chr22_+_22686724 | 2.35 |
ENST00000390305.2
|
IGLV3-25
|
immunoglobulin lambda variable 3-25 |
chr12_+_103587266 | 2.31 |
ENST00000388887.7
|
STAB2
|
stabilin 2 |
chr1_+_160739265 | 2.30 |
ENST00000368042.7
|
SLAMF7
|
SLAM family member 7 |
chr1_+_160739239 | 2.26 |
ENST00000368043.8
|
SLAMF7
|
SLAM family member 7 |
chr1_-_157777124 | 2.22 |
ENST00000361516.8
ENST00000368181.4 |
FCRL2
|
Fc receptor like 2 |
chr6_-_132763424 | 2.22 |
ENST00000532012.1
ENST00000525270.5 ENST00000530536.5 ENST00000524919.5 |
VNN2
|
vanin 2 |
chr11_+_61102465 | 2.21 |
ENST00000347785.8
ENST00000544014.1 |
CD5
|
CD5 molecule |
chr7_-_142813394 | 2.20 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 |
chr9_-_34710069 | 2.17 |
ENST00000378792.1
ENST00000259607.7 |
CCL21
|
C-C motif chemokine ligand 21 |
chr22_+_22747383 | 2.16 |
ENST00000390311.3
|
IGLV3-16
|
immunoglobulin lambda variable 3-16 |
chr4_+_155854758 | 2.16 |
ENST00000506072.5
ENST00000507590.5 |
TDO2
|
tryptophan 2,3-dioxygenase |
chr7_+_150991087 | 2.16 |
ENST00000461406.5
|
NOS3
|
nitric oxide synthase 3 |
chr14_-_106005574 | 2.13 |
ENST00000390595.3
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr4_+_40197023 | 2.12 |
ENST00000381799.10
|
RHOH
|
ras homolog family member H |
chr2_+_201116396 | 2.11 |
ENST00000395148.6
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr2_+_97713568 | 2.11 |
ENST00000264972.10
|
ZAP70
|
zeta chain of T cell receptor associated protein kinase 70 |
chr19_+_45506579 | 2.11 |
ENST00000589627.1
|
VASP
|
vasodilator stimulated phosphoprotein |
chr12_-_14951106 | 2.10 |
ENST00000541644.5
ENST00000545895.5 |
ARHGDIB
|
Rho GDP dissociation inhibitor beta |
chr22_+_22030934 | 2.08 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr22_+_22771791 | 2.08 |
ENST00000390313.3
|
IGLV3-12
|
immunoglobulin lambda variable 3-12 |
chr16_+_30182969 | 2.06 |
ENST00000561815.5
|
CORO1A
|
coronin 1A |
chr3_-_58210961 | 2.06 |
ENST00000486455.5
ENST00000394549.7 |
DNASE1L3
|
deoxyribonuclease 1 like 3 |
chr6_-_32816910 | 2.05 |
ENST00000447394.1
ENST00000438763.7 |
HLA-DOB
|
major histocompatibility complex, class II, DO beta |
chr14_-_105845677 | 2.02 |
ENST00000390556.6
|
IGHD
|
immunoglobulin heavy constant delta |
chr3_+_30606574 | 2.02 |
ENST00000295754.10
ENST00000359013.4 |
TGFBR2
|
transforming growth factor beta receptor 2 |
chr1_-_153549120 | 2.00 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr16_+_30182795 | 1.99 |
ENST00000563778.5
|
CORO1A
|
coronin 1A |
chrX_-_71111448 | 1.98 |
ENST00000456850.6
ENST00000473378.1 ENST00000374202.7 ENST00000374188.7 |
IL2RG
|
interleukin 2 receptor subunit gamma |
chr22_+_22880706 | 1.97 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr22_-_37149900 | 1.96 |
ENST00000216223.10
|
IL2RB
|
interleukin 2 receptor subunit beta |
chr2_+_90154073 | 1.95 |
ENST00000611391.1
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr20_+_46008900 | 1.95 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 |
chr9_-_134917872 | 1.95 |
ENST00000616356.4
ENST00000371806.4 |
FCN1
|
ficolin 1 |
chr3_+_32951636 | 1.95 |
ENST00000330953.6
|
CCR4
|
C-C motif chemokine receptor 4 |
chr19_-_46625037 | 1.94 |
ENST00000596260.1
ENST00000594275.1 ENST00000597185.1 ENST00000598865.5 ENST00000291294.7 |
PTGIR
|
prostaglandin I2 receptor |
chr2_-_88947820 | 1.94 |
ENST00000496168.1
|
IGKV1-5
|
immunoglobulin kappa variable 1-5 |
chr19_-_15464525 | 1.93 |
ENST00000343625.12
|
RASAL3
|
RAS protein activator like 3 |
chr6_+_131573219 | 1.92 |
ENST00000356962.2
ENST00000368087.8 ENST00000673427.1 ENST00000640973.1 |
ARG1
|
arginase 1 |
chr12_-_10130241 | 1.92 |
ENST00000353231.9
ENST00000525605.1 |
CLEC7A
|
C-type lectin domain containing 7A |
chr2_-_68952880 | 1.91 |
ENST00000481498.1
ENST00000328895.9 |
GKN2
|
gastrokine 2 |
chr2_-_89213917 | 1.91 |
ENST00000498435.1
|
IGKV1-27
|
immunoglobulin kappa variable 1-27 |
chr12_-_10130143 | 1.91 |
ENST00000298523.9
ENST00000396484.6 ENST00000310002.4 ENST00000304084.13 |
CLEC7A
|
C-type lectin domain containing 7A |
chr4_-_83114715 | 1.89 |
ENST00000426923.2
ENST00000311507.9 ENST00000509973.5 |
PLAC8
|
placenta associated 8 |
chr12_+_101475319 | 1.89 |
ENST00000551346.2
|
SPIC
|
Spi-C transcription factor |
chr17_-_35880350 | 1.89 |
ENST00000605140.6
ENST00000651122.1 ENST00000603197.6 |
CCL5
|
C-C motif chemokine ligand 5 |
chr2_+_89851723 | 1.88 |
ENST00000429992.2
|
IGKV2D-40
|
immunoglobulin kappa variable 2D-40 |
chr12_-_95996302 | 1.86 |
ENST00000261208.8
ENST00000538703.5 ENST00000541929.5 |
HAL
|
histidine ammonia-lyase |
chr14_-_24634266 | 1.85 |
ENST00000382540.5
|
GZMB
|
granzyme B |
chr1_-_153549238 | 1.83 |
ENST00000368713.8
|
S100A3
|
S100 calcium binding protein A3 |
chr12_+_69348372 | 1.83 |
ENST00000261267.7
ENST00000549690.1 ENST00000548839.1 |
LYZ
|
lysozyme |
chrY_+_12904860 | 1.81 |
ENST00000336079.8
|
DDX3Y
|
DEAD-box helicase 3 Y-linked |
chr16_+_28931942 | 1.81 |
ENST00000324662.8
ENST00000538922.8 |
CD19
|
CD19 molecule |
chr19_+_49928702 | 1.80 |
ENST00000595125.5
|
ATF5
|
activating transcription factor 5 |
chr14_+_21846534 | 1.79 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
chr19_+_49929196 | 1.78 |
ENST00000423777.7
ENST00000600336.1 ENST00000597227.5 |
ATF5
|
activating transcription factor 5 |
chr1_+_223701607 | 1.77 |
ENST00000434648.5
|
CAPN2
|
calpain 2 |
chr14_-_106579223 | 1.76 |
ENST00000390626.2
|
IGHV5-51
|
immunoglobulin heavy variable 5-51 |
chr10_-_79560386 | 1.75 |
ENST00000372327.9
ENST00000417041.1 ENST00000640627.1 ENST00000372325.7 |
SFTPA2
|
surfactant protein A2 |
chr14_+_20891385 | 1.73 |
ENST00000304639.4
|
RNASE3
|
ribonuclease A family member 3 |
chr22_+_22098683 | 1.70 |
ENST00000390283.2
|
IGLV8-61
|
immunoglobulin lambda variable 8-61 |
chr2_+_90190193 | 1.69 |
ENST00000390278.3
|
IGKV1D-42
|
immunoglobulin kappa variable 1D-42 (non-functional) |
chr12_-_9869345 | 1.69 |
ENST00000228438.3
|
CLEC2B
|
C-type lectin domain family 2 member B |
chr7_+_142450941 | 1.69 |
ENST00000390368.2
|
TRBV6-5
|
T cell receptor beta variable 6-5 |
chr9_-_114074969 | 1.68 |
ENST00000466610.6
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
chr4_+_73740541 | 1.67 |
ENST00000401931.1
ENST00000307407.8 |
CXCL8
|
C-X-C motif chemokine ligand 8 |
chr1_-_203229660 | 1.67 |
ENST00000255427.7
ENST00000367229.6 |
CHIT1
|
chitinase 1 |
chr11_+_78063851 | 1.65 |
ENST00000281030.2
|
THRSP
|
thyroid hormone responsive |
chr22_+_22375984 | 1.62 |
ENST00000390296.2
|
IGLV5-45
|
immunoglobulin lambda variable 5-45 |
chr2_+_90021567 | 1.62 |
ENST00000436451.2
|
IGKV6D-21
|
immunoglobulin kappa variable 6D-21 (non-functional) |
chr2_-_196171565 | 1.62 |
ENST00000263955.9
|
STK17B
|
serine/threonine kinase 17b |
chr11_-_57410113 | 1.61 |
ENST00000529411.1
|
ENSG00000254979.5
|
novel protein |
chr8_-_17895403 | 1.60 |
ENST00000381840.5
ENST00000398054.5 |
FGL1
|
fibrinogen like 1 |
chr8_-_17895487 | 1.59 |
ENST00000427924.5
ENST00000381841.4 |
FGL1
|
fibrinogen like 1 |
chr16_+_56608577 | 1.59 |
ENST00000245185.6
ENST00000561491.1 |
MT2A
|
metallothionein 2A |
chr14_+_21918161 | 1.59 |
ENST00000390439.2
|
TRAV13-2
|
T cell receptor alpha variable 13-2 |
chr15_-_21742799 | 1.57 |
ENST00000622410.2
|
ENSG00000278263.2
|
novel protein, identical to IGHV4-4 |
chr10_-_6062290 | 1.56 |
ENST00000256876.10
ENST00000379954.5 |
IL2RA
|
interleukin 2 receptor subunit alpha |
chr19_+_40991274 | 1.55 |
ENST00000324071.10
|
CYP2B6
|
cytochrome P450 family 2 subfamily B member 6 |
chr14_+_21997531 | 1.54 |
ENST00000390445.2
|
TRAV17
|
T cell receptor alpha variable 17 |
chr10_-_14008521 | 1.54 |
ENST00000640906.1
|
FRMD4A
|
FERM domain containing 4A |
chr12_-_53200443 | 1.54 |
ENST00000550743.6
|
ITGB7
|
integrin subunit beta 7 |
chr2_-_157439403 | 1.53 |
ENST00000418920.5
|
CYTIP
|
cytohesin 1 interacting protein |
chr3_+_63967738 | 1.52 |
ENST00000484332.1
|
ATXN7
|
ataxin 7 |
chr22_+_22792485 | 1.50 |
ENST00000390314.2
|
IGLV2-11
|
immunoglobulin lambda variable 2-11 |
chr11_-_118342645 | 1.48 |
ENST00000529594.5
|
CD3D
|
CD3d molecule |
chr2_-_174597728 | 1.48 |
ENST00000409891.5
ENST00000410117.5 |
WIPF1
|
WAS/WASL interacting protein family member 1 |
chr4_-_73982019 | 1.47 |
ENST00000296029.4
|
PF4
|
platelet factor 4 |
chr12_-_102481744 | 1.47 |
ENST00000644491.1
|
IGF1
|
insulin like growth factor 1 |
chr4_-_39032343 | 1.47 |
ENST00000381938.4
|
TMEM156
|
transmembrane protein 156 |
chr10_+_30434602 | 1.46 |
ENST00000413724.5
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr15_-_19965101 | 1.46 |
ENST00000338912.5
|
IGHV1OR15-9
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
chr11_-_102724945 | 1.46 |
ENST00000236826.8
|
MMP8
|
matrix metallopeptidase 8 |
chr6_+_106086316 | 1.45 |
ENST00000369091.6
ENST00000369096.9 |
PRDM1
|
PR/SET domain 1 |
chr7_+_74209989 | 1.44 |
ENST00000361082.7
ENST00000275635.11 ENST00000460943.6 ENST00000470709.1 |
LAT2
|
linker for activation of T cells family member 2 |
chr2_+_85694350 | 1.44 |
ENST00000524600.5
ENST00000263863.9 |
GNLY
|
granulysin |
chr11_-_65662780 | 1.43 |
ENST00000534283.1
ENST00000527749.5 ENST00000533187.5 ENST00000525693.5 ENST00000534558.5 ENST00000532879.5 ENST00000406246.8 ENST00000532999.5 |
RELA
|
RELA proto-oncogene, NF-kB subunit |
chr12_-_54295748 | 1.43 |
ENST00000540264.2
ENST00000312156.8 |
NFE2
|
nuclear factor, erythroid 2 |
chr2_+_201116940 | 1.43 |
ENST00000433445.1
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr7_+_150737382 | 1.42 |
ENST00000358647.5
|
GIMAP5
|
GTPase, IMAP family member 5 |
chr17_-_5234801 | 1.42 |
ENST00000571800.5
ENST00000574081.6 ENST00000399600.8 ENST00000574297.1 |
SCIMP
|
SLP adaptor and CSK interacting membrane protein |
chr5_+_55102635 | 1.42 |
ENST00000274306.7
|
GZMA
|
granzyme A |
chr14_-_106507476 | 1.41 |
ENST00000390621.3
|
IGHV1-45
|
immunoglobulin heavy variable 1-45 |
chr10_-_5978022 | 1.41 |
ENST00000525219.6
|
IL15RA
|
interleukin 15 receptor subunit alpha |
chr7_+_150991005 | 1.40 |
ENST00000297494.8
|
NOS3
|
nitric oxide synthase 3 |
chr2_+_201116793 | 1.40 |
ENST00000441224.5
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr1_+_168576595 | 1.40 |
ENST00000367818.4
|
XCL1
|
X-C motif chemokine ligand 1 |
chr7_+_150567347 | 1.40 |
ENST00000461940.5
|
GIMAP4
|
GTPase, IMAP family member 4 |
chr11_-_67356970 | 1.40 |
ENST00000532830.5
|
POLD4
|
DNA polymerase delta 4, accessory subunit |
chr8_-_17910357 | 1.40 |
ENST00000398056.6
|
FGL1
|
fibrinogen like 1 |
chr7_+_150567382 | 1.39 |
ENST00000255945.4
ENST00000479232.1 |
GIMAP4
|
GTPase, IMAP family member 4 |
chr3_-_27722699 | 1.39 |
ENST00000461503.2
|
EOMES
|
eomesodermin |
chr7_-_150632333 | 1.38 |
ENST00000493969.2
ENST00000328902.9 |
GIMAP6
|
GTPase, IMAP family member 6 |
chr15_-_79971164 | 1.37 |
ENST00000335661.6
ENST00000267953.4 ENST00000677151.1 |
BCL2A1
|
BCL2 related protein A1 |
chr7_+_80602150 | 1.37 |
ENST00000309881.11
|
CD36
|
CD36 molecule |
chr17_-_45425620 | 1.37 |
ENST00000376922.6
|
ARHGAP27
|
Rho GTPase activating protein 27 |
chr10_+_5094405 | 1.36 |
ENST00000380554.5
|
AKR1C3
|
aldo-keto reductase family 1 member C3 |
chr4_-_99290975 | 1.36 |
ENST00000209668.3
|
ADH1A
|
alcohol dehydrogenase 1A (class I), alpha polypeptide |
chr2_+_89936859 | 1.36 |
ENST00000474213.1
|
IGKV2D-30
|
immunoglobulin kappa variable 2D-30 |
chr11_-_111379268 | 1.35 |
ENST00000393067.8
|
POU2AF1
|
POU class 2 homeobox associating factor 1 |
chr1_+_161706949 | 1.35 |
ENST00000350710.3
ENST00000367949.6 ENST00000367959.6 ENST00000540521.5 ENST00000546024.5 ENST00000674251.1 ENST00000674323.1 |
FCRLA
|
Fc receptor like A |
chr1_-_113871665 | 1.35 |
ENST00000528414.5
ENST00000460620.5 ENST00000359785.10 ENST00000420377.6 ENST00000525799.1 ENST00000538253.5 |
PTPN22
|
protein tyrosine phosphatase non-receptor type 22 |
chr2_+_90082635 | 1.34 |
ENST00000483379.1
|
IGKV1D-17
|
immunoglobulin kappa variable 1D-17 |
chr16_+_33827140 | 1.34 |
ENST00000562905.2
|
IGHV3OR16-13
|
immunoglobulin heavy variable 3/OR16-13 (non-functional) |
chr2_+_85694399 | 1.34 |
ENST00000409696.7
|
GNLY
|
granulysin |
chr4_+_40200320 | 1.33 |
ENST00000511121.5
|
RHOH
|
ras homolog family member H |
chr6_+_63211446 | 1.33 |
ENST00000370659.1
|
FKBP1C
|
FKBP prolyl isomerase family member 1C |
chr5_-_180815563 | 1.33 |
ENST00000513431.5
ENST00000514438.1 |
MGAT1
|
alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase |
chr19_-_19628512 | 1.32 |
ENST00000588461.1
|
LPAR2
|
lysophosphatidic acid receptor 2 |
chr3_-_58214671 | 1.32 |
ENST00000460422.1
ENST00000483681.5 |
DNASE1L3
|
deoxyribonuclease 1 like 3 |
chr11_-_118342616 | 1.31 |
ENST00000392884.2
|
CD3D
|
CD3d molecule |
chr2_+_201116238 | 1.31 |
ENST00000342795.9
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
chr19_-_42528380 | 1.31 |
ENST00000403461.5
ENST00000352591.9 ENST00000358394.7 ENST00000403444.7 ENST00000161559.11 ENST00000599389.1 |
CEACAM1
|
CEA cell adhesion molecule 1 |
chr2_-_89297785 | 1.30 |
ENST00000465170.1
|
IGKV1-37
|
immunoglobulin kappa variable 1-37 (non-functional) |
chr17_+_21288029 | 1.30 |
ENST00000526076.6
ENST00000361818.9 ENST00000316920.10 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
chr5_+_136059151 | 1.30 |
ENST00000503087.1
|
TGFBI
|
transforming growth factor beta induced |
chr1_+_160796157 | 1.30 |
ENST00000263285.11
ENST00000368039.2 |
LY9
|
lymphocyte antigen 9 |
chr14_+_21894433 | 1.30 |
ENST00000390438.2
|
TRAV8-4
|
T cell receptor alpha variable 8-4 |
chr19_+_41549510 | 1.30 |
ENST00000407170.6
ENST00000601116.5 ENST00000595395.1 |
CEACAM21
ENSG00000268027.5
|
CEA cell adhesion molecule 21 novel transcript, sense intronic to CEACAM21 |
chr7_-_150632644 | 1.30 |
ENST00000618759.4
|
GIMAP6
|
GTPase, IMAP family member 6 |
chrY_+_2841864 | 1.29 |
ENST00000430575.1
|
RPS4Y1
|
ribosomal protein S4 Y-linked 1 |
chr12_-_57478070 | 1.29 |
ENST00000549602.1
ENST00000430041.6 |
ARHGAP9
|
Rho GTPase activating protein 9 |
chr19_+_45668191 | 1.29 |
ENST00000652180.1
ENST00000590918.6 ENST00000263281.7 ENST00000304207.12 |
GIPR
|
gastric inhibitory polypeptide receptor |
chr10_-_6062349 | 1.28 |
ENST00000379959.8
|
IL2RA
|
interleukin 2 receptor subunit alpha |
chr22_-_23754376 | 1.28 |
ENST00000398465.3
ENST00000248948.4 |
VPREB3
|
V-set pre-B cell surrogate light chain 3 |
chr1_-_161550591 | 1.28 |
ENST00000367967.7
ENST00000436743.6 ENST00000442336.1 |
FCGR3A
|
Fc fragment of IgG receptor IIIa |
chrX_-_19670983 | 1.28 |
ENST00000379716.5
|
SH3KBP1
|
SH3 domain containing kinase binding protein 1 |
chr12_+_55931070 | 1.27 |
ENST00000555090.5
|
DGKA
|
diacylglycerol kinase alpha |
chr19_+_54630410 | 1.26 |
ENST00000396327.7
ENST00000324602.12 |
LILRB1
|
leukocyte immunoglobulin like receptor B1 |
chr1_+_27392612 | 1.25 |
ENST00000374024.4
|
GPR3
|
G protein-coupled receptor 3 |
chr14_+_20469399 | 1.25 |
ENST00000361505.10
ENST00000553591.1 |
PNP
|
purine nucleoside phosphorylase |
chr2_+_201122477 | 1.25 |
ENST00000425030.1
|
CFLAR
|
CASP8 and FADD like apoptosis regulator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
1.3 | 3.8 | GO:0006714 | sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) regulation of testosterone biosynthetic process(GO:2000224) |
1.0 | 13.6 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
1.0 | 4.0 | GO:0050712 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.9 | 4.7 | GO:0032796 | uropod organization(GO:0032796) |
0.9 | 2.8 | GO:0002818 | intracellular defense response(GO:0002818) |
0.9 | 4.4 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.9 | 2.6 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
0.8 | 3.4 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.8 | 3.3 | GO:0035548 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
0.7 | 2.2 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.7 | 1.4 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.7 | 2.0 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.7 | 6.8 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.7 | 2.0 | GO:0060434 | bronchus morphogenesis(GO:0060434) |
0.6 | 1.9 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.6 | 1.9 | GO:0099553 | trans-synaptic signaling by lipid, modulating synaptic transmission(GO:0099552) trans-synaptic signaling by endocannabinoid, modulating synaptic transmission(GO:0099553) |
0.6 | 1.8 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.6 | 5.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 94.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.6 | 1.7 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.5 | 2.7 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.5 | 2.1 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 3.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.5 | 4.4 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.5 | 6.8 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.5 | 1.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.5 | 1.0 | GO:0034226 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
0.5 | 1.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 0.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
0.5 | 1.4 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.4 | 1.3 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
0.4 | 1.8 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.4 | 2.6 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.4 | 2.1 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.4 | 1.7 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.4 | 1.2 | GO:2000627 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) regulation of miRNA catabolic process(GO:2000625) positive regulation of miRNA catabolic process(GO:2000627) |
0.4 | 0.8 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
0.4 | 6.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.4 | 1.1 | GO:2001025 | response to cyclosporin A(GO:1905237) positive regulation of response to drug(GO:2001025) |
0.4 | 2.6 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.4 | 1.4 | GO:0052417 | multi-organism catabolic process(GO:0044035) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
0.4 | 0.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.4 | 2.1 | GO:1903904 | negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
0.3 | 1.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.3 | 2.0 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 1.0 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
0.3 | 2.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 1.0 | GO:0032701 | negative regulation of interleukin-18 production(GO:0032701) |
0.3 | 1.6 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.3 | 2.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.3 | 4.2 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.3 | 1.0 | GO:0010931 | macrophage tolerance induction(GO:0010931) regulation of macrophage tolerance induction(GO:0010932) positive regulation of macrophage tolerance induction(GO:0010933) |
0.3 | 0.9 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.3 | 2.5 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 1.2 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.3 | 1.5 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.3 | 5.3 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.3 | 1.2 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
0.3 | 1.5 | GO:1904073 | regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.3 | 1.5 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.3 | 0.6 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.3 | 1.2 | GO:0010607 | negative regulation of cytoplasmic mRNA processing body assembly(GO:0010607) |
0.3 | 1.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 5.4 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.3 | 3.9 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 3.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.3 | 1.9 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.3 | 1.1 | GO:0018277 | protein deamination(GO:0018277) |
0.3 | 1.1 | GO:0002268 | follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
0.3 | 1.3 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.3 | 1.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.3 | 2.3 | GO:0015793 | glycerol transport(GO:0015793) |
0.3 | 0.8 | GO:0009720 | detection of hormone stimulus(GO:0009720) |
0.3 | 1.3 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.3 | 0.8 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.3 | 0.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 0.8 | GO:0035698 | CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.2 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.2 | 0.7 | GO:0015734 | taurine transport(GO:0015734) |
0.2 | 0.2 | GO:2001188 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:2001188) |
0.2 | 1.5 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.2 | 5.2 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.2 | 0.9 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.2 | 1.4 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.2 | 0.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 0.7 | GO:0030221 | basophil differentiation(GO:0030221) |
0.2 | 0.7 | GO:0002194 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.2 | 1.1 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 0.7 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.2 | 48.2 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 0.7 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.2 | 0.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
0.2 | 1.1 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.2 | 3.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 0.9 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.2 | 1.3 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.2 | 2.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 1.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.2 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.2 | 2.2 | GO:0008228 | opsonization(GO:0008228) |
0.2 | 0.4 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.2 | 0.8 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) cellular response to folic acid(GO:0071231) |
0.2 | 0.6 | GO:1901656 | glycoside transport(GO:1901656) |
0.2 | 1.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.2 | 1.0 | GO:0038156 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 1.1 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.2 | 0.8 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.2 | 1.1 | GO:0090294 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
0.2 | 0.6 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.2 | 1.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.2 | 0.7 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.2 | 0.4 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.2 | 3.6 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.2 | 1.4 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.2 | 1.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 0.9 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.2 | 1.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 1.5 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
0.2 | 0.7 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 1.0 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.2 | 0.6 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.2 | 0.6 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 0.5 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.5 | GO:0044007 | negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010768) transmission of virus(GO:0019089) dissemination or transmission of symbiont from host(GO:0044007) development involved in symbiotic interaction(GO:0044111) dissemination or transmission of organism from other organism involved in symbiotic interaction(GO:0051821) |
0.2 | 0.8 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.2 | 0.9 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.2 | 1.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.2 | 11.9 | GO:0002228 | natural killer cell mediated immunity(GO:0002228) |
0.2 | 0.5 | GO:2000506 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) regulation of small intestine smooth muscle contraction(GO:1904347) positive regulation of small intestine smooth muscle contraction(GO:1904349) small intestine smooth muscle contraction(GO:1990770) negative regulation of energy homeostasis(GO:2000506) |
0.2 | 1.7 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.9 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.2 | 2.1 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.2 | 0.6 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.1 | 0.4 | GO:0045425 | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
0.1 | 0.7 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.1 | 0.7 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.1 | 1.9 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.1 | 1.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.9 | GO:0050904 | diapedesis(GO:0050904) |
0.1 | 0.3 | GO:2000485 | regulation of glutamine transport(GO:2000485) |
0.1 | 0.9 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 1.1 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 0.9 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.1 | 1.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 0.4 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.1 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.1 | 1.8 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 4.8 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.1 | 0.4 | GO:0072183 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of nephron tubule epithelial cell differentiation(GO:0072183) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) negative regulation of epithelial cell differentiation involved in kidney development(GO:2000697) |
0.1 | 1.7 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 14.8 | GO:0045576 | mast cell activation(GO:0045576) |
0.1 | 3.4 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.7 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.1 | 3.6 | GO:0021930 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 1.0 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 1.6 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 1.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.1 | 1.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.1 | 0.7 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.8 | GO:0044805 | late nucleophagy(GO:0044805) |
0.1 | 1.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.5 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.1 | 0.5 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.3 | GO:0031296 | B cell costimulation(GO:0031296) |
0.1 | 0.5 | GO:0052047 | positive regulation of fibrinolysis(GO:0051919) interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
0.1 | 0.5 | GO:0060734 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.1 | 0.4 | GO:0036323 | vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
0.1 | 0.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 2.0 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.6 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.1 | 0.4 | GO:0052314 | phytoalexin metabolic process(GO:0052314) |
0.1 | 0.6 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) negative regulation of activation of membrane attack complex(GO:0001971) |
0.1 | 4.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.1 | 0.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 1.4 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
0.1 | 1.4 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.6 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.1 | 3.1 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 1.9 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.4 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 1.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 1.2 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 1.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.1 | 0.3 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.5 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.9 | GO:0070836 | caveola assembly(GO:0070836) |
0.1 | 0.3 | GO:0042938 | dipeptide transport(GO:0042938) |
0.1 | 3.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.1 | 0.9 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.1 | 0.4 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.1 | 0.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.5 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.1 | 0.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.4 | GO:0014011 | Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
0.1 | 1.6 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.1 | 1.9 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.1 | 1.3 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.1 | 2.4 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 0.3 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.1 | 1.4 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.1 | 0.8 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.1 | 1.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.9 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 0.5 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.1 | 0.5 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.4 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.1 | 1.0 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.5 | GO:0045337 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.1 | 0.3 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) germ-line stem cell population maintenance(GO:0030718) |
0.1 | 0.5 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
0.1 | 0.5 | GO:0015783 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
0.1 | 0.4 | GO:0051413 | response to cortisone(GO:0051413) |
0.1 | 1.1 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.1 | 0.2 | GO:0045355 | negative regulation of interferon-alpha biosynthetic process(GO:0045355) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
0.1 | 0.6 | GO:0007343 | egg activation(GO:0007343) |
0.1 | 1.3 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
0.1 | 0.3 | GO:0033590 | response to cobalamin(GO:0033590) |
0.1 | 0.4 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 1.4 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.4 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.5 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 1.1 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.1 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.1 | 1.0 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.1 | 2.1 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.1 | 0.2 | GO:0001300 | chronological cell aging(GO:0001300) |
0.1 | 1.3 | GO:0010744 | positive regulation of macrophage derived foam cell differentiation(GO:0010744) |
0.1 | 0.5 | GO:2000373 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.7 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
0.1 | 0.4 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 0.5 | GO:0045357 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) |
0.1 | 0.4 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.8 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 7.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.9 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0033320 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 | 1.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.2 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.7 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 1.4 | GO:0042730 | fibrinolysis(GO:0042730) |
0.1 | 0.8 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.1 | 0.1 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
0.1 | 1.4 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 2.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 3.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.3 | GO:0006175 | adenosine salvage(GO:0006169) dATP biosynthetic process(GO:0006175) |
0.1 | 4.4 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.1 | 1.2 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.1 | 0.3 | GO:1903615 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.1 | 0.9 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.4 | GO:0075044 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) CAMKK-AMPK signaling cascade(GO:0061762) autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.5 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.1 | 0.9 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.4 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.1 | 2.0 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.2 | GO:0034059 | response to anoxia(GO:0034059) |
0.1 | 0.6 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.5 | GO:1904637 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.1 | 0.3 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
0.1 | 0.3 | GO:0032571 | response to vitamin K(GO:0032571) |
0.1 | 0.1 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.1 | 0.3 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
0.1 | 0.5 | GO:0090625 | mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
0.1 | 0.4 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 2.7 | GO:0071539 | protein localization to centrosome(GO:0071539) |
0.1 | 0.5 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.2 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.1 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.2 | GO:1902283 | negative regulation of primary amine oxidase activity(GO:1902283) |
0.1 | 0.2 | GO:0060981 | cell migration involved in coronary angiogenesis(GO:0060981) |
0.1 | 0.9 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.5 | GO:1903207 | neuron death in response to hydrogen peroxide(GO:0036476) regulation of hydrogen peroxide-induced neuron death(GO:1903207) negative regulation of hydrogen peroxide-induced neuron death(GO:1903208) |
0.1 | 1.3 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.6 | GO:0046449 | creatinine metabolic process(GO:0046449) |
0.1 | 0.2 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.1 | 1.3 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
0.1 | 2.1 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.3 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 1.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 2.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 0.7 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.7 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.1 | 1.0 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.8 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 5.3 | GO:0031294 | lymphocyte costimulation(GO:0031294) |
0.1 | 1.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.2 | GO:1901073 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
0.1 | 0.2 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 2.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.3 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.4 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.1 | 1.7 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.0 | 0.4 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.0 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.0 | 0.3 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
0.0 | 0.2 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.2 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.0 | 0.8 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.4 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.0 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.3 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.0 | 2.2 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.0 | 0.6 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 1.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.0 | 0.3 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 0.2 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.6 | GO:0097324 | melanocyte migration(GO:0097324) positive regulation of lens fiber cell differentiation(GO:1902748) |
0.0 | 0.2 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.0 | 0.2 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
0.0 | 0.1 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.0 | 0.8 | GO:0032329 | serine transport(GO:0032329) |
0.0 | 0.2 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.0 | 0.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.0 | 0.1 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.0 | 0.6 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.2 | GO:1904800 | regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
0.0 | 0.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.0 | 1.2 | GO:0006298 | mismatch repair(GO:0006298) |
0.0 | 0.4 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.0 | 0.1 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.0 | 0.4 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.0 | 0.3 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.0 | 0.4 | GO:0006848 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.0 | 0.1 | GO:0018160 | peptidyl-pyrromethane cofactor linkage(GO:0018160) |
0.0 | 1.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 2.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.1 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.0 | 0.3 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.0 | 1.5 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 2.5 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.0 | 0.2 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
0.0 | 0.5 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
0.0 | 0.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 1.6 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.0 | GO:0046219 | serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.0 | 0.6 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.0 | 0.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.4 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.0 | 0.5 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.7 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.5 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.0 | 2.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.6 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
0.0 | 0.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.0 | 0.3 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.6 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.3 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.0 | 0.2 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) positive regulation of metalloendopeptidase activity(GO:1904685) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.0 | 2.1 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.0 | 0.3 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.0 | 6.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.3 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 1.2 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.8 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.1 | GO:1902943 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.0 | 0.4 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.0 | 0.3 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 0.6 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.4 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.5 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.9 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.1 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.0 | 0.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.0 | 0.3 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.0 | 0.4 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.3 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.0 | 0.2 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.0 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.9 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.4 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.0 | 0.4 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.0 | 0.4 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.0 | 0.1 | GO:0042732 | xylulose metabolic process(GO:0005997) D-xylose metabolic process(GO:0042732) |
0.0 | 0.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.0 | 0.5 | GO:0072310 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.0 | 0.1 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
0.0 | 0.7 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.0 | 0.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.2 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.0 | 0.3 | GO:0019835 | cytolysis(GO:0019835) |
0.0 | 0.9 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 0.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.3 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 1.4 | GO:0035329 | hippo signaling(GO:0035329) |
0.0 | 1.8 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 1.6 | GO:0001824 | blastocyst development(GO:0001824) |
0.0 | 0.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.2 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 1.2 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.1 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.4 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.3 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.0 | 0.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.1 | GO:0000451 | rRNA 2'-O-methylation(GO:0000451) |
0.0 | 0.8 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.0 | 0.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.9 | GO:0050868 | negative regulation of T cell activation(GO:0050868) |
0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.4 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.6 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.2 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.0 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.5 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.0 | 0.1 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.0 | 0.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 1.7 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.3 | GO:0015866 | ADP transport(GO:0015866) |
0.0 | 0.4 | GO:0097320 | membrane tubulation(GO:0097320) |
0.0 | 0.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.0 | 0.1 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.0 | 1.1 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.9 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.4 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.0 | 0.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.5 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.3 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.7 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.0 | 0.1 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.0 | 0.1 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.0 | 0.2 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.0 | 0.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 1.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.0 | 0.6 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.0 | 0.2 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.0 | 0.4 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.0 | 0.3 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.0 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.0 | 0.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.0 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.0 | 0.2 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.0 | 7.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.1 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 0.3 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.0 | 0.1 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.0 | 0.1 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 4.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.2 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.1 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.1 | GO:1902950 | regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
0.0 | 0.1 | GO:0035948 | regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter(GO:0035947) positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.0 | 0.1 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.0 | 0.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.0 | 0.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.2 | GO:0006105 | succinate metabolic process(GO:0006105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 3.4 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.6 | 15.5 | GO:0097342 | ripoptosome(GO:0097342) |
0.6 | 3.4 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.5 | 1.6 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 2.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 2.8 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.4 | 5.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 4.9 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 2.0 | GO:0036502 | Derlin-1-VIMP complex(GO:0036502) |
0.4 | 2.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.4 | 21.9 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.4 | 1.4 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.3 | 2.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 1.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 1.0 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
0.3 | 1.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.3 | 1.5 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.3 | 2.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 22.5 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 1.4 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.3 | 1.1 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 2.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.3 | 1.0 | GO:0036398 | TCR signalosome(GO:0036398) |
0.3 | 2.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.2 | 4.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 0.9 | GO:0045259 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) proton-transporting ATP synthase complex(GO:0045259) |
0.2 | 0.2 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
0.2 | 1.4 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 2.6 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.2 | 2.5 | GO:0060171 | stereocilium membrane(GO:0060171) |
0.2 | 1.2 | GO:0044753 | amphisome(GO:0044753) |
0.2 | 0.7 | GO:0035517 | PR-DUB complex(GO:0035517) |
0.2 | 1.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 35.0 | GO:0072562 | blood microparticle(GO:0072562) |
0.2 | 0.5 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.2 | 1.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.2 | 0.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.5 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 0.4 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.4 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) CNTFR-CLCF1 complex(GO:0097059) |
0.1 | 0.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.1 | 0.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.1 | 1.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 1.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 1.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 3.3 | GO:0042599 | lamellar body(GO:0042599) |
0.1 | 0.5 | GO:0034677 | integrin alpha7-beta1 complex(GO:0034677) |
0.1 | 0.6 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.1 | 0.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.1 | 10.5 | GO:0035580 | specific granule lumen(GO:0035580) |
0.1 | 0.2 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.1 | 0.4 | GO:0035101 | FACT complex(GO:0035101) |
0.1 | 0.6 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 1.1 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 37.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 1.3 | GO:0097413 | Lewy body(GO:0097413) |
0.1 | 3.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.3 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
0.1 | 8.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.1 | 1.8 | GO:0042627 | chylomicron(GO:0042627) |
0.1 | 2.1 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.1 | 0.4 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.1 | 0.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.1 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 9.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 1.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 0.1 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.1 | 2.3 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 0.5 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.1 | 1.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 0.7 | GO:0098560 | cytoplasmic side of early endosome membrane(GO:0098559) cytoplasmic side of late endosome membrane(GO:0098560) |
0.1 | 1.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.1 | 0.5 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.1 | 5.9 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 7.0 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 4.3 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.7 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.6 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 1.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.9 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.0 | 0.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.0 | 0.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.0 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 1.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 4.5 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.0 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.9 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 3.0 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 0.4 | GO:0000796 | condensin complex(GO:0000796) |
0.0 | 4.3 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) RISC-loading complex(GO:0070578) |
0.0 | 0.5 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 0.6 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.0 | 0.2 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 1.2 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.2 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 1.4 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 7.6 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.1 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 5.0 | GO:0016605 | PML body(GO:0016605) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.5 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 1.0 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.2 | GO:0031906 | late endosome lumen(GO:0031906) |
0.0 | 0.1 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0016342 | catenin complex(GO:0016342) |
0.0 | 0.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.0 | 0.5 | GO:0031932 | TORC2 complex(GO:0031932) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 0.1 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.0 | 0.2 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.0 | 0.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 1.4 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 33.9 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.0 | 0.8 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.0 | 0.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.3 | GO:0005915 | zonula adherens(GO:0005915) |
0.0 | 0.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 1.6 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.0 | GO:0044207 | eukaryotic 48S preinitiation complex(GO:0033290) translation initiation ternary complex(GO:0044207) |
0.0 | 1.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 2.3 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.0 | 0.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.3 | 3.8 | GO:0045550 | geranylgeranyl reductase activity(GO:0045550) |
1.2 | 4.8 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.8 | 3.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.8 | 4.0 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.7 | 0.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.7 | 2.1 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.7 | 0.7 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.7 | 2.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.6 | 4.2 | GO:0019862 | IgA binding(GO:0019862) |
0.6 | 2.2 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.6 | 1.7 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.5 | 2.7 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.5 | 2.1 | GO:0061609 | fructose-1-phosphate aldolase activity(GO:0061609) |
0.5 | 2.1 | GO:0030395 | lactose binding(GO:0030395) |
0.5 | 138.7 | GO:0003823 | antigen binding(GO:0003823) |
0.5 | 1.5 | GO:0015432 | bile acid-exporting ATPase activity(GO:0015432) |
0.4 | 3.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.4 | 15.2 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.4 | 9.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.6 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.4 | 3.7 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 2.8 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.4 | 1.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.4 | 1.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.4 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 0.8 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.4 | 1.1 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.4 | 1.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.4 | 1.1 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.4 | 1.1 | GO:0004615 | phosphomannomutase activity(GO:0004615) |
0.3 | 1.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 1.0 | GO:0017129 | triglyceride binding(GO:0017129) |
0.3 | 1.0 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.3 | 3.7 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.3 | 1.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.3 | 2.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.3 | 1.9 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.3 | 10.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.3 | 1.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.3 | 2.8 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 2.2 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.3 | 0.9 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.3 | 1.2 | GO:0033265 | choline binding(GO:0033265) |
0.3 | 0.9 | GO:0052815 | medium-chain acyl-CoA hydrolase activity(GO:0052815) long-chain acyl-CoA hydrolase activity(GO:0052816) |
0.3 | 3.5 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 1.1 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.3 | 0.9 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.3 | 1.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 2.9 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 2.6 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.3 | 1.0 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 0.7 | GO:0005368 | taurine transmembrane transporter activity(GO:0005368) taurine:sodium symporter activity(GO:0005369) |
0.2 | 6.9 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.2 | 1.2 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
0.2 | 0.7 | GO:0051717 | bisphosphoglycerate phosphatase activity(GO:0034416) inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
0.2 | 0.7 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
0.2 | 1.4 | GO:0034597 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.2 | 1.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.2 | 0.9 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.2 | 0.7 | GO:0052871 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.2 | 5.0 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.1 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.2 | 1.5 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 7.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.2 | 0.8 | GO:0061714 | folic acid receptor activity(GO:0061714) |
0.2 | 0.6 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
0.2 | 1.0 | GO:0004914 | interleukin-3 receptor activity(GO:0004912) interleukin-5 receptor activity(GO:0004914) |
0.2 | 1.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.2 | 0.8 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.2 | 4.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.8 | GO:0043273 | CTPase activity(GO:0043273) |
0.2 | 1.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.2 | 1.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 2.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.2 | 1.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 0.7 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.2 | 3.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.2 | 0.5 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 0.9 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 0.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
0.2 | 0.5 | GO:0047787 | delta4-3-oxosteroid 5beta-reductase activity(GO:0047787) |
0.2 | 0.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.2 | 0.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.3 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.2 | 0.3 | GO:0032427 | GBD domain binding(GO:0032427) |
0.2 | 1.0 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.2 | 0.6 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.2 | 0.5 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.2 | 1.2 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.2 | 1.1 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.2 | 0.8 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 0.6 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.2 | 0.5 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 3.2 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.4 | GO:0035605 | peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
0.1 | 1.3 | GO:0004875 | complement receptor activity(GO:0004875) |
0.1 | 0.6 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 1.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 4.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 2.2 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 0.8 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.1 | 0.5 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 0.9 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.1 | 0.7 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.9 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 0.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.1 | 0.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.4 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
0.1 | 0.9 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 2.7 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 1.4 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.4 | GO:0036332 | VEGF-A-activated receptor activity(GO:0036326) VEGF-B-activated receptor activity(GO:0036327) placental growth factor-activated receptor activity(GO:0036332) |
0.1 | 4.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 0.9 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 1.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 0.8 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
0.1 | 0.8 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.1 | 1.4 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.7 | GO:0004882 | androgen receptor activity(GO:0004882) |
0.1 | 1.9 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 1.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.1 | 0.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 2.2 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.1 | 0.7 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.1 | 0.7 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 0.3 | GO:0019808 | diamine N-acetyltransferase activity(GO:0004145) polyamine binding(GO:0019808) |
0.1 | 0.6 | GO:0039552 | RIG-I binding(GO:0039552) |
0.1 | 0.3 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 0.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.1 | 0.8 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 2.0 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 0.4 | GO:0003978 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.1 | 0.8 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
0.1 | 0.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
0.1 | 0.5 | GO:0004161 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.1 | 1.8 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.5 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.1 | 0.5 | GO:0050610 | glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.1 | 0.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 1.3 | GO:0019864 | IgG binding(GO:0019864) |
0.1 | 0.3 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.1 | 0.7 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.6 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.1 | 0.3 | GO:0015182 | L-histidine transmembrane transporter activity(GO:0005290) L-asparagine transmembrane transporter activity(GO:0015182) |
0.1 | 1.0 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 0.3 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) aromatase activity(GO:0070330) |
0.1 | 0.8 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.4 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 1.7 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.1 | 0.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 0.3 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.2 | GO:0050051 | leukotriene-B4 20-monooxygenase activity(GO:0050051) |
0.1 | 0.3 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.1 | 1.2 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 2.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.1 | 0.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.1 | 0.2 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.1 | 1.2 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 0.2 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.1 | 1.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 3.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.1 | 0.5 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.1 | 0.2 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
0.1 | 0.6 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.6 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 1.0 | GO:0031419 | cobalamin binding(GO:0031419) |
0.1 | 0.3 | GO:0004001 | adenosine kinase activity(GO:0004001) |
0.1 | 0.2 | GO:0009384 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
0.1 | 0.5 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.1 | 0.3 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.1 | 1.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 0.8 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.5 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.1 | 0.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.1 | 1.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 2.9 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.1 | 0.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 0.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.7 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 2.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.3 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 0.9 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.1 | 0.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.1 | 7.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 0.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 2.0 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.8 | GO:0046935 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.1 | 2.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.1 | 1.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 3.2 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.1 | 0.1 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.1 | 0.7 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 8.0 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 1.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 2.9 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.2 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 2.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.2 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.1 | 0.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.1 | 0.4 | GO:0038051 | glucocorticoid receptor activity(GO:0004883) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.1 | 1.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 0.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.0 | 0.5 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.4 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.0 | 0.1 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.5 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 0.3 | GO:0004310 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.0 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.4 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0052595 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.0 | 0.8 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.6 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.0 | 1.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.0 | 0.3 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.0 | 0.2 | GO:0005019 | platelet activating factor receptor activity(GO:0004992) platelet-derived growth factor beta-receptor activity(GO:0005019) |
0.0 | 12.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 2.4 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.0 | 0.4 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.0 | 0.7 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.6 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.0 | 1.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.2 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.1 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
0.0 | 0.8 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.2 | GO:0051538 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.0 | 0.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.0 | 0.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.0 | 0.5 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 1.4 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.0 | 0.3 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 1.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.0 | 0.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 2.0 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.4 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.0 | 1.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 1.1 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0004040 | amidase activity(GO:0004040) |
0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.0 | 2.9 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0070039 | rRNA (guanosine-2'-O-)-methyltransferase activity(GO:0070039) |
0.0 | 0.4 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.3 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.0 | 0.2 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.3 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.0 | 0.5 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.0 | 0.9 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.3 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.6 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.7 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 1.9 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 0.2 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.0 | 1.5 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.3 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.0 | 1.6 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.0 | 0.2 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.0 | 0.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.0 | 0.8 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.0 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 0.2 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.0 | 0.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.5 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.5 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.3 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.0 | 0.3 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.0 | 0.5 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.4 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 1.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.1 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.4 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.0 | 2.4 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.0 | 0.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.4 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 2.0 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.0 | 1.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.1 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.3 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.3 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.9 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.0 | GO:0033862 | UMP kinase activity(GO:0033862) |
0.0 | 0.2 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 3.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.3 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.0 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.0 | 1.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 4.6 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 0.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 15.8 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 1.0 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 26.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.2 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.2 | 4.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 8.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 4.9 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 6.7 | PID BCR 5PATHWAY | BCR signaling pathway |
0.1 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 0.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 3.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 6.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 4.1 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 2.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 5.8 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 8.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 3.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.1 | 0.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.1 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 1.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.1 | 7.4 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.1 | 3.8 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.4 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 5.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 1.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 2.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.1 | 4.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 5.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 6.5 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 5.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 13.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.4 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.4 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 2.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 2.1 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 4.2 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 9.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 10.5 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 3.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.5 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 1.0 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 1.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.1 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.0 | 0.3 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.2 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.4 | PID IFNG PATHWAY | IFN-gamma pathway |
0.0 | 1.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.6 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.5 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 1.6 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 15.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 8.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 18.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 4.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.2 | 6.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 3.7 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.2 | 2.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.3 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.2 | 6.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 4.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 5.2 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 2.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 2.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.2 | 3.6 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 2.5 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 4.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 1.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 2.2 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.3 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 4.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.1 | 3.6 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 2.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 6.4 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.1 | 1.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 2.0 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.1 | 7.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 12.7 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.1 | 4.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 1.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.9 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.4 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.1 | 2.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 1.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 0.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.1 | 0.8 | REACTOME GPCR DOWNSTREAM SIGNALING | Genes involved in GPCR downstream signaling |
0.1 | 7.2 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 1.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 2.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.1 | 2.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 1.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 0.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.2 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.1 | 4.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 2.1 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.7 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
0.0 | 14.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.9 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.0 | 0.8 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 2.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.9 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 1.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 3.4 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 2.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 1.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 1.2 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.3 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 0.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 2.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.0 | 1.0 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.2 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 3.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.0 | 0.5 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 2.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.0 | 0.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.0 | 1.8 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.4 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 1.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 2.9 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.1 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.0 | 0.4 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.5 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 0.0 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.0 | 0.1 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.5 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.9 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 0.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.1 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.0 | 0.5 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.5 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 0.5 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 3.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |